Literature DB >> 24030419

Thymosin β4 increases the potency of transplanted mesenchymal stem cells for myocardial repair.

Lei Ye1, Pengyuan Zhang, Sue Duval, Liping Su, Qiang Xiong, Jianyi Zhang.   

Abstract

BACKGROUND: Thymosin β4 (Tβ4) has been shown to enhance the survival of cultured cardiomyocytes. Here, we investigated whether the cytoprotective effects of Tβ4 can increase the effectiveness of transplanted swine mesenchymal stem cells (sMSCs) for cardiac repair in a rat model of myocardial infarction (MI). METHODS AND
RESULTS: Under hypoxic conditions, cellular damage (lactate dehydrogenase leakage), apoptosis (terminal deoxynucleotidyl transferase dUTP nick end labelingc cells), and caspase-8 activity were significantly lower, whereas B-cell lymphoma-extra large protein expression was significantly higher, in sMSCs cultured with Tβ4 (1 μg/mL) than in sMSCs cultured without Tβ4, and Tβ4 also increased sMSC proliferation. For in vivo experiments, animals were treated with basal medium (MI: n=6), a fibrin patch (Patch: n=6), a patch containing sMSCs (sMSC: n=9), or a patch containing sMSCs and Tβ4 (sMSC/Tβ4: n=11); Tβ4 was encapsulated in gelatin microspheres to extend Tβ4 delivery. Four weeks after treatment, echocardiographic assessments of left-ventricular ejection fraction and fractional shortening were significantly better (P<0.05) in sMSC/Tβ4 animals (left-ventricular ejection fraction=51.7 ± 1.1%; fractional shortening=26.7 ± 0.7%) than in animals from MI (39 ± 3%; 19.5 ± 1.7%) and Patch (43 ± 1.4%; 21.6 ± 0.9%) groups. Histological assessment of infarct wall thickness was significantly higher (P<0.05) in sMSC/Tβ4 animals (50%, [45%, 80%]) than in animals from MI (25%, [20%, 25%]) group. Measurements in sMSC (left-ventricular ejection fraction=45 ± 2.6%; fractional shortening=22.9 ± 1.6%; TH = 43% [25%, 45%]), Patch, and MI animals were similar. Tβ4 administration also significantly increased vascular growth, the retention/survival of the transplanted sMSCs, and the recruitment of endogenous c-Kit(+) progenitor cells to the infarcted region.
CONCLUSIONS: Extended-release Tβ4 administration improves the retention, survival, and regenerative potency of transplanted sMSCs after myocardial injury.

Entities:  

Keywords:  angiogenesis; microsphere; myocardial infarction; stem cell; tissue engineering

Mesh:

Substances:

Year:  2013        PMID: 24030419      PMCID: PMC3886821          DOI: 10.1161/CIRCULATIONAHA.112.000025

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  34 in total

1.  Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology.

Authors:  D R Plas; S Talapatra; A L Edinger; J C Rathmell; C B Thompson
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

2.  Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation.

Authors:  Konstantinos E Hatzistergos; Henry Quevedo; Behzad N Oskouei; Qinghua Hu; Gary S Feigenbaum; Irene S Margitich; Ramesh Mazhari; Andrew J Boyle; Juan P Zambrano; Jose E Rodriguez; Raul Dulce; Pradip M Pattany; David Valdes; Concepcion Revilla; Alan W Heldman; Ian McNiece; Joshua M Hare
Journal:  Circ Res       Date:  2010-07-29       Impact factor: 17.367

3.  Controlled release of thymosin β4 using collagen-chitosan composite hydrogels promotes epicardial cell migration and angiogenesis.

Authors:  Loraine L Y Chiu; Milica Radisic
Journal:  J Control Release       Date:  2011-05-30       Impact factor: 9.776

4.  Thymosin beta4 promotes matrix metalloproteinase expression during wound repair.

Authors:  Deborah Philp; Brooke Scheremeta; Kedesha Sibliss; Min Zhou; Esther L Fine; Mychi Nguyen; Larry Wahl; Matthew P Hoffman; Hynda K Kleinman
Journal:  J Cell Physiol       Date:  2006-07       Impact factor: 6.384

5.  Monitoring of bone marrow cell homing into the infarcted human myocardium.

Authors:  Michael Hofmann; Kai C Wollert; Gerd P Meyer; Alix Menke; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Wolfram H Knapp; Helmut Drexler
Journal:  Circulation       Date:  2005-04-25       Impact factor: 29.690

6.  The actin binding site on thymosin beta4 promotes angiogenesis.

Authors:  Deborah Philp; Thomas Huff; Yong Song Gho; Ewald Hannappel; Hynda K Kleinman
Journal:  FASEB J       Date:  2003-09-18       Impact factor: 5.191

7.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

Review 8.  Paracrine mechanisms in adult stem cell signaling and therapy.

Authors:  Massimiliano Gnecchi; Zhiping Zhang; Aiguo Ni; Victor J Dzau
Journal:  Circ Res       Date:  2008-11-21       Impact factor: 17.367

9.  Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization.

Authors:  Nicola Smart; Catherine A Risebro; Athalie A D Melville; Kelvin Moses; Robert J Schwartz; Kenneth R Chien; Paul R Riley
Journal:  Nature       Date:  2006-11-15       Impact factor: 49.962

10.  Mesenchymal stem cells avoid allogeneic rejection.

Authors:  Jennifer M Ryan; Frank P Barry; J Mary Murphy; Bernard P Mahon
Journal:  J Inflamm (Lond)       Date:  2005-07-26       Impact factor: 4.981

View more
  31 in total

1.  Enhancing endothelial progenitor cell for clinical use.

Authors:  Lei Ye; Kian-Keong Poh
Journal:  World J Stem Cells       Date:  2015-07-26       Impact factor: 5.326

Review 2.  Stem Cell Homing: a Potential Therapeutic Strategy Unproven for Treatment of Myocardial Injury.

Authors:  Zhonghao Tao; Shihua Tan; Wen Chen; Xin Chen
Journal:  J Cardiovasc Transl Res       Date:  2018-10-15       Impact factor: 4.132

3.  A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy.

Authors:  Jeffrey E Cohen; Brendan P Purcell; John W MacArthur; Anbin Mu; Yasuhiro Shudo; Jay B Patel; Christopher M Brusalis; Alen Trubelja; Alexander S Fairman; Bryan B Edwards; Mollie S Davis; George Hung; William Hiesinger; Pavan Atluri; Kenneth B Margulies; Jason A Burdick; Y Joseph Woo
Journal:  Circ Heart Fail       Date:  2014-06-05       Impact factor: 8.790

4.  IL-11 is a crucial determinant of cardiovascular fibrosis.

Authors:  Sebastian Schafer; Sivakumar Viswanathan; Anissa A Widjaja; Wei-Wen Lim; Aida Moreno-Moral; Daniel M DeLaughter; Benjamin Ng; Giannino Patone; Kingsley Chow; Ester Khin; Jessie Tan; Sonia P Chothani; Lei Ye; Owen J L Rackham; Nicole S J Ko; Norliza E Sahib; Chee Jian Pua; Nicole T G Zhen; Chen Xie; Mao Wang; Henrike Maatz; Shiqi Lim; Kathrin Saar; Susanne Blachut; Enrico Petretto; Sabine Schmidt; Tracy Putoczki; Nuno Guimarães-Camboa; Hiroko Wakimoto; Sebastiaan van Heesch; Kristmundur Sigmundsson; See L Lim; Jia L Soon; Victor T T Chao; Yeow L Chua; Teing E Tan; Sylvia M Evans; Yee J Loh; Muhammad H Jamal; Kim K Ong; Kim C Chua; Boon-Hean Ong; Mathew J Chakaramakkil; Jonathan G Seidman; Christine E Seidman; Norbert Hubner; Kenny Y K Sin; Stuart A Cook
Journal:  Nature       Date:  2017-11-13       Impact factor: 49.962

Review 5.  "Second-generation" stem cells for cardiac repair.

Authors:  Alberto Núñez García; Ricardo Sanz-Ruiz; María Eugenia Fernández Santos; Francisco Fernández-Avilés
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

6.  Tβ4 Increases Neovascularization and Cardiac Function in Chronic Myocardial Ischemia of Normo- and Hypercholesterolemic Pigs.

Authors:  Tilman Ziegler; Andrea Bähr; Andrea Howe; Katharina Klett; Wira Husada; Christian Weber; Karl-Ludwig Laugwitz; Christian Kupatt; Rabea Hinkel
Journal:  Mol Ther       Date:  2018-06-19       Impact factor: 11.454

7.  Thymosin β4 impeded murine stem cell proliferation with an intact cardiovascular differentiation.

Authors:  Li Nie; Shi-Jun Gao; Ya-Nan Zhao; Jacob Masika; Hong-Yan Luo; Xin-Wu Hu; Liang-Pin Zhang; Ying Zeng; Jürgen Hescheler; Hua-Min Liang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-05

Review 8.  Differentiation and Application of Human Pluripotent Stem Cells Derived Cardiovascular Cells for Treatment of Heart Diseases: Promises and Challenges.

Authors:  Yu Gao; Jun Pu
Journal:  Front Cell Dev Biol       Date:  2021-05-12

9.  Thymosin β4 released from functionalized self-assembling peptide activates epicardium and enhances repair of infarcted myocardium.

Authors:  Yong-Li Wang; Shu-Na Yu; Hao-Ran Shen; Hai-Jie Wang; Xue-Ping Wu; Qiang-Li Wang; Bin Zhou; Yu-Zhen Tan
Journal:  Theranostics       Date:  2021-02-20       Impact factor: 11.556

10.  TMSB4 Overexpression Enhances the Potency of Marrow Mesenchymal Stromal Cells for Myocardial Repair.

Authors:  Shiyuan Tang; Chengming Fan; Chukwuemeka Daniel Iroegbu; Wenwu Zhou; Zhigong Zhang; Ming Wu; Wangping Chen; Xiaoming Wu; Jun Peng; Zhihong Li; Jinfu Yang
Journal:  Front Cell Dev Biol       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.